{"id":64666,"date":"2025-02-14T00:01:43","date_gmt":"2025-02-14T00:01:43","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/02\/14\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/"},"modified":"2025-02-14T00:01:43","modified_gmt":"2025-02-14T00:01:43","slug":"profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/","title":{"rendered":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow"},"content":{"rendered":"<div>\n<p align=\"justify\">TORONTO, Feb.  13, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_CBu7zskpus8g2C1ERB_Zc2pCdzFCADvWHI8XoLAzIpAsYKXPBieF0Pok-lha5ISc5Dgi_2QrSkefLJ4JGz6ugtg5ARXoe7uwedxzEgB4kI=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>Profound Medical Corp.<\/u><\/a> (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025.<\/p>\n<p align=\"justify\">Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.<\/p>\n<p align=\"justify\"><strong>Fourth Quarter and Full Year 2024 Results Conference Call Details:<\/strong><\/p>\n<p align=\"justify\">Date: Thursday, March 6, 2025<\/p>\n<p align=\"justify\">Time: 4:30 p.m. ET<\/p>\n<p align=\"justify\">Live Call Registration: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=d4kCoqo0FU_fd34v6QAsma5DwSGUCTIL7VAi09aGtcloc0tAeZrVfDkxtTMYBm7jMfyQy_AwmXUujU1xP0PJ6Pe-G6DQBBNmiM3pljOyHsI68uEMMwoV9nNwqdSWWKzcdg8Hh3kFnpfJP3-v_K64PGWPbOyZrrU1RjXt7AkFnskmHPSXcQ8SW5RpGg-xduf4bqiVC5ZQwRNxF7cHvMtZy_FKfBVjIP5oYqyOQer_8rc=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>https:\/\/register.vevent.com\/register\/BI4fc1c4c3061645ca9f513f8f017abfbb<\/u><\/a><\/p>\n<p align=\"justify\">The call will also be broadcast live and archived on the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2NVOqDhl5kuMuA7S1hPesn0QKLs0szKOqbbLyLV3cyjFLqFpnhRo5qFUBCFuzOnKI5ZBxkXz1AiMuEoe-neVigc0X02NjdAoXcdUSdOOeEg=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>www.profoundmedical.com<\/u><\/a> under \u201cWebcasts\u201d in the Investors section.<\/p>\n<p align=\"justify\"><strong>About Profound Medical Corp.<\/strong><\/p>\n<p align=\"justify\">Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.<\/p>\n<p align=\"justify\">Profound is commercializing TULSA-PRO<sup>\u00ae<\/sup>, a technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO<sup>\u00ae<\/sup> system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (\u201cBPH\u201d); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. TULSA employs real-time MR guidance for precision to preserve patients\u2019 urinary continence and sexual function, while killing the targeted prostate tissue via precise sound absorption technology that gently heats it to 55-57\u00b0C. TULSA is an incision- and radiation-free \u201cone-and-done\u201d procedure performed in a single session that takes a few hours. Virtually all prostate shapes and sizes can be safely, effectively, and efficiently treated with TULSA. There is no bleeding associated with the procedure; no hospital stay is required; and most TULSA patients report quick recovery to their normal routine. TULSA-PRO<sup>\u00ae<\/sup> is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration (\u201cFDA\u201d).<\/p>\n<p align=\"justify\">Profound is also commercializing Sonalleve<sup>\u00ae<\/sup>, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Sonalleve<sup>\u00ae<\/sup> has also been approved by the China National Medical Products Administration for the non-invasive treatment of uterine fibroids and has FDA approval under a Humanitarian Device Exemption for the treatment of osteoid osteoma. The Company is in the early stages of exploring additional potential treatment markets for Sonalleve<sup>\u00ae<\/sup> where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy.<\/p>\n<p align=\"justify\"><strong>For further information, please contact:<\/strong><\/p>\n<p align=\"justify\">Stephen Kilmer<br \/>Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zrcs2_V8gHOpa5MPs46HE7LQOGIfgv_ve4l08EX0ANraFVSn7Igi3BN2oYkrModOhoPOxvBcj8_P70xOfuXcPIXZW-yfYGFDkMftKJHXmdFqEHIcfJxDlrbQJ1L3z_vm\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>skilmer@profoundmedical.com<\/u><\/a> <br \/>T: 647.872.4849<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NGY4NTkxMzAtMTE1My00YTI2LTkwMzUtNmVjNGM4Nzc4NWRmLTEwMzAxMTk=\/tiny\/Profound-Medical-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025. Profound management [&#8230;]\n","protected":false},"author":1,"featured_media":64667,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64666","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow\" \/>\n<meta property=\"og:description\" content=\"TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stag\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-14T00:01:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Profound-Medical-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow\",\"datePublished\":\"2025-02-14T00:01:43+00:00\",\"dateModified\":\"2025-02-14T00:01:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/\"},\"wordCount\":468,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/\",\"name\":\"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-02-14T00:01:43+00:00\",\"dateModified\":\"2025-02-14T00:01:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/","og_locale":"en_US","og_type":"article","og_title":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow","og_description":"TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stag","og_url":"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-02-14T00:01:43+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Profound-Medical-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow","datePublished":"2025-02-14T00:01:43+00:00","dateModified":"2025-02-14T00:01:43+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/"},"wordCount":468,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/","url":"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/","name":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-02-14T00:01:43+00:00","dateModified":"2025-02-14T00:01:43+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/profound-medical-to-release-fourth-quarter-and-full-year-2024-financial-results-on-march-6-conference-call-to-follow\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 \u2013 Conference Call to Follow"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=64666"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64666\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/64667"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=64666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=64666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=64666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}